EMA And Dutch Govt Eye July Signing Of Deal To Move Agency To Amsterdam
The EMA and the Dutch authorities are expected to sign the agreement on the agency’s new home in Amsterdam on July 1. The agreement is aimed at ensuring the agency can function properly once it relocates, and describes how the Dutch government will treat the agency and its staff.
You may also be interested in...
The EMA is to further refocus on its core activities to help it deal with “higher than expected” staff losses due to its relocation to Amsterdam.
France is exploring the use of hydroxychloroquine and lopinavir/ritonavir in COVID-19, but only in hospitalized patients and in clinical trials, and has banned all exports of the products to avoid possible shortages.
Efforts are under way in the UK on many fronts to develop new treatments and vaccines for coronavirus infection, including researching new uses of existing products and clinical trials of new vaccines.